RNAseq of immune features in melanoma patients

NIAID Data Ecosystem2026-05-01 收录

肿瘤治疗响应

RNA测序特征分析

数据链接：

https://www.ncbi.nlm.nih.gov/sra/ERP137551 数据链接链接失效反馈

官方服务：

资源简介：

RNAseq data from tumors obtained from melanoma patients with advanced disease and treated with anti-PD1 inhibitors.

创建时间：

2023-10-13

Differential response to Lenalidomide from WT and RUNX1-KO MDS-L del(5q) cells. Differential response to Lenalidomide from WT and RUNX1-KO MDS-L del(5q) cells

肿瘤治疗响应

基因功能缺失

We used CRISPR/Cas9 system to generate WT Control and RUNX1-KO MDS-L cells isolated as single clones from the parental MDS-L cell line. We have observed that RUNX1-KO MDS-L cells are resistant to Lena

NIAID Data Ecosystem100

Circulating SOD2 is a Response Biomarker for Neoadjuvant Therapy in Breast Cancer

肿瘤治疗响应

液体活检

There is a great need of non-invasive tools that inform of an early molecular response to cancer therapeutic treatment. Here, we have tested the hypothesis that proteolytically resistant proteins coul

NIAID Data Ecosystem60

Trends in colorectal cancer stage 1975–2012.

结直肠癌分期

肿瘤治疗响应

1. No lymph nodes assessed or no comment about lymph node positivity. 2. Complete pathologic response (i.e. ypT0N0) following neoadjuvant therapy.

NIAID Data Ecosystem30

Multi-Omics Biomarkers of Response to Immunotherapy in Combination with Epigenetic Modulators

肿瘤治疗响应

生物标志物研究

Epigenetic immunomodulation by association of guadecitabine with ipilimumab (NIBIT-M4 Phase Ib trial, NCT02608437) has been shown to be safe and tolerable in advanced melanoma and to have significant

NIAID Data Ecosystem80

MicroRNA expression in peripheral blood predicts poor and prolonged response to sunitinib.

肿瘤治疗响应

癌症生物标志物

Peripheral blood samples were taken before initiation of therapy and 2 weeks later from patients with advanced renal cell carcinoma treated with sunitinib in first line. MicroRNA expression in periphe

NIAID Data Ecosystem40

RNAseq of immune features in melanoma patients

资源简介：

相关数据集